A new observational study supports a link between long-term dutasteride treatment and sexual side effects, including worsening erectile dysfunction (ED) and reduced testosterone levels. Use of the 5-alpha reductase inhibitor (5-ARI) was also associated with several parameters of metabolic dysfunction, including increased glucose and hemoglobin A1c and lipid abnormalities.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
